If you are having difficulty viewing this newsletter, please click here.

November 2008

	Do you want to stay updated? Subscribe to our eNewsletter now!
	CLICK HERE!
	Would you like to contribute to this eNewsletter?
	CLICK HERE!

	Do you know someone who would be interested in reading this? Forward this page to him/her!
	CLICK HERE!

		Developing Fusion Proteins for Therapeutics In a recent webcast, noted pharmaceutical experts discussed the value of using fusion proteins for therapeutic treatments — and the challenges that manufacturers need to overcome.

		What's Happening Single-use bioreactors add to Laureate Pharma's flexibility; a new contract manufacturing agreement kicks off; and events provide educational opportunities for scientists and manufacturers.

		Fusion Proteins: Productivity, Production and Product Development Dr. Howard L. Levine, Founder, President, and Principal Consultant for BioProcess Technology Consultants, answers some important questions about fusion proteins.

		Purifying Fusion Proteins: Expect the Unexpected In this case study, learn how Laureate Pharma designed a customized process for purifying fusion proteins.

		"If we all did the things we are capable of doing, we would literally astound ourselves." — Thomas A. Edison

cGMP CONDITIONS. ON TIME DELIVERY. WITH LAUREATE PHARMA, IT'S IN THE VIAL.^TM

Laureate Pharma, Inc. 201 College Road East Princeton, New Jersey 08540 1.609.919.3300 info@laureatepharma.com

Click here to unsubscribe from Laureate Pharma eNewsletter list.